Introduction: In the course of allogeneic hematopoietic cell transplantation (allo-HCT) the donor’s hematopoietic progenitor cells are exposed to immense proliferative stress to reconstitute in the recipient the functional hematopoiesis. Moreover, recipients who develop infections or chronic graft-versus-host disease (GvHD) are subjected to further proliferative stress, especially in the lymphocyte subset. We hypothesized that allo-HCT may induce changes in proinflammatory cytokines profile and immunophenotype in the allo-HCT recipients, especially in patients with a chronic GvHD history. Material and methods: We compared the cytokine profile [interleukin (IL)-6, IL-10, and tumor necrosis factor α (TNF-α)] between long-term allo-HCT recipie...
Acute graft-versus-host disease (GVHD), relapse and graft rejection are the main complications after...
dissertationChronic graft-versus-host disease (cGVHD) is a prevalent late effect of allogeneic hemat...
Allogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immunotherapy agai...
Understanding the biologic milieu associated with differing symptom profiles in allogeneic HSCT surv...
Chronic graft versus host disease (cGVHD) is a common long-term complication after allogeneic hemato...
The only curative treatment strategy for many hematologic and inborn immunodeficiency disorders is ...
BACKGROUND Allogeneic hematopoietic cell transplantation (HCT) can be devastating when graft-vers...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Allogeneic bone marrow transplantation (BMT) is utilised as a curative therapy for haematological ma...
Although it is commonly accepted that allogeneic hematopoietic cell transplant (HCT) recipients deve...
Differences in major and minor histocompatibility antigens between donor and recipient trigger power...
Differences in major and minor histocompatibility antigens between donor and recipient trigger power...
Acute graft-versus-host disease (GVHD), relapse and graft rejection are the main complications after...
dissertationChronic graft-versus-host disease (cGVHD) is a prevalent late effect of allogeneic hemat...
Allogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immunotherapy agai...
Understanding the biologic milieu associated with differing symptom profiles in allogeneic HSCT surv...
Chronic graft versus host disease (cGVHD) is a common long-term complication after allogeneic hemato...
The only curative treatment strategy for many hematologic and inborn immunodeficiency disorders is ...
BACKGROUND Allogeneic hematopoietic cell transplantation (HCT) can be devastating when graft-vers...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Allogeneic bone marrow transplantation (BMT) is utilised as a curative therapy for haematological ma...
Although it is commonly accepted that allogeneic hematopoietic cell transplant (HCT) recipients deve...
Differences in major and minor histocompatibility antigens between donor and recipient trigger power...
Differences in major and minor histocompatibility antigens between donor and recipient trigger power...
Acute graft-versus-host disease (GVHD), relapse and graft rejection are the main complications after...
dissertationChronic graft-versus-host disease (cGVHD) is a prevalent late effect of allogeneic hemat...
Allogeneic hematopoietic cell transplantation (alloHCT) has been used as cellular immunotherapy agai...